Join us at the FDA/CMS Summit, THE biopharma event that facilitates direct dialogue between biopharma executives, investors and FDA/CMS regulators to explain complex regulatory and reimbursement policy.
The Alliance for Aging Research commented on the Centers for Medicare & Medicaid Services (CMS) proposed rule changes regarding Infection Prevention and Control Programs (IPCP) in long-term care facilities (LTCFs). The Alliance recommended:
A full implementation madate within two years of the final rule
Mandating the CDC's National Healthcare Safety Network (NHSN) for surveillance of Healthcare Associated Infections by LTCFs
CMS work directly with the CDC to outline specific programs that LTCFs should follow to fulfill mandates
CMS should mandate the CDC's CORE Elements for Antibiotic Stewardship in LTCFs
Contact information for an Infection Prevention and Control Officer (IPCO) be made publicly available for family members of LTCF patients
CMS should provide language mandating the use of influenza vaccinations among direct-contact health care workers in LTCFs and set targets for vaccination rates